Efficacy and Safety of Ashwagandha Root Extract on Cognitive Functions in Healthy, Stressed Adults: A Randomized, Double-Blind, Placebo-Controlled Study

Author:

Gopukumar Kumarpillai1,Thanawala Shefali2ORCID,Somepalli Venkateswarlu3ORCID,Rao T. S. Sathyanaryana4,Thamatam Vijaya Bhaskar5ORCID,Chauhan Sanjaya5

Affiliation:

1. Bengaluru Neuro Centre, Bengaluru, Karnataka 560003, India

2. Inventia Healthcare Ltd., Mumbai, Maharashtra 400069, India

3. Laila Nutraceuticals, Vijayawada, Andhra Pradesh 520007, India

4. Sumana Vinayaka Nursing Home, Mandya, Karnataka 571401, India

5. In Vitro Research Solutions (iVRS) Pvt Ltd., Bengaluru, Karnataka 560092, India

Abstract

Background. The global prevalence of stress is increasing. Stress adversely affects cognitive ability, sleep quality, and overall psychological well-being. Ashwagandha (Withania somnifera (L.) Dunal), an essential medicine in Ayurveda, is reportedly beneficial in reducing stress and improving memory. This double-blind, randomized, placebo-controlled clinical study evaluated the effect of Ashwagandha root extract sustained-release capsule 300 mg (Prolanza™; hereafter Ashwagandha SR) on cognitive functions, stress levels, sleep quality, overall well-being, and safety in stressed subjects. Methods. Subjects (130 healthy cognitively sound adults [20–55 years, body mass index:18–29 kg/m2]) having a Perceived Stress Scale (PSS) score of 14–24 were randomized to receive either Ashwagandha SR or placebo. Subjects took one capsule of Ashwagandha SR or placebo daily for 90 consecutive days. This study was registered on Clinical Trials Registry-India (CTRI) on 13/11/2019 [number: CTRI/2019/11/021990]. The primary endpoint was the change in cognitive function as measured by CANTAB from baseline to the end of the study period (90 ± 7 days). The secondary outcomes included the change in PSS-10 score, serum cortisol level (9–11 am), the OHQ score, the PSQI, and serum BDNF levels. Results. Only 125 completed the study and were evaluated. The Cambridge Neuropsychological Test Automated Battery (CANTAB) reported significantly improved recall memory, and the total error rate in recalling patterns significantly decreased at visit 4 in the Ashwagandha SR group vs. the placebo group (first attempt memory score:12.9 ± 6.7 vs. 10.1 ± 6.3; total errors:17.5 ± 23.3 vs. 27.7 ± 23.6). At visit 4, lower PSS-10 score (13.0 ± 5.0 vs. 18.7 ± 4.6; p < .0001 ), serum cortisol levels p = 0.0443 , and Pittsburgh Sleep Quality Index (PSQI) score p < .0001 but higher Oxford Happiness Questionnaire (OHQ) scores p < .0001 were seen in Ashwagandha SR vs. the placebo group, suggesting significantly lower stress levels and significantly better psychological well-being and sleep quality in the former. No adverse events were reported. Conclusions. This is the first clinical study assessing Ashwagandha SR for its safety and efficacy. Treatment with one Ashwagandha SR capsule once daily for 90 days improved memory and focus, psychological well-being, and sleep quality, reduced stress levels, and was safe and well-tolerated.

Funder

Inventia Healthcare Ltd.

Publisher

Hindawi Limited

Subject

Complementary and alternative medicine

Reference34 articles.

1. Prevalence of stress, anxiety, depression among the general population during the COVID-19 pandemic: a systematic review and meta-analysis;S. Nader;Globalization and Health,2020

2. Stress and cognition;W. Jianhui;Frontiers in Psychology,2017

3. Stress and cognition in humans;D. Gregor;Journal of Experimental Psychology,2020

4. The influence of sleep on human hypothalamic–pituitary–adrenal (HPA) axis reactivity: A systematic review

5. The role of sleep quality, trait anxiety and hypothalamic-pituitary-adrenal axis measures in cognitive abilities of healthy individuals;J. Labad;International Journal of Environmental Research and Public Health,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3